Posted on 4/24/19
Merkle Releases Its Q1 2019 Digital Marketing Report
COLUMBIA, Md.--(BUSINESS WIRE)--Merkle (www.merkleinc.com), a leading technology-enabled, data-driven performance marketing agency, has released its Q1 2019 Digital Marketing Report (DMR). The full report analyzes key trends . . .
Posted on 4/23/19
DrFirst Structures a New $17 Million Commercial Financing Facility with SunTrust
DrFirst, the nation's leading provider of e-prescribing, price transparency, and medication management solutions, announced today that it has structured a new $17 million commercial financing facility . . .
Posted on 4/23/19
HealthWell Foundation Opens New Amyloidosis Fund
The HealthWell Foundation, an independent non-profit that provides a financial lifeline for inadequately insured Americans, has launched a new fund to provide copayment and premium assistance . . .
Posted on 4/23/19
D4C Dental Brands Open New Offices in Laurel, Maryland
D4C Dental Brands, which provides non-clinical support to pediatric dental and orthodontic practices, is hosting a grand opening to celebrate its newest supported practices in Laurel, . . .
Posted on 4/23/19
RegeneRx Publishes Annual Letter to Shareholders
RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX), a clinical-stage drug development company focused on tissue protection, repair and regeneration, today published its annual letter to stockholders on the . . .
Posted on 4/23/19
Orgenesis Announces Collaboration Agreement with Columbia University
GERMANTOWN, Md., April 22, 2019 (GLOBE NEWSWIRE) -- Orgenesis Inc. (NASDAQ: ORGS), a developer of advanced cell therapies, manufacturer and service provider, today announced that it . . .
Posted on 4/22/19
Lorien Health Services Voted “Best Elder Care” Company
Winners of the Baltimore Sun's Best Readers’ Choice Poll were determined by popular vote. Lorien Health Services, a family-owned nursing home, assisted living and rehabilitation company, . . .
Posted on 4/22/19
GlycoMimetics Announces Publication of Nature Cell Biology Paper Supporting Recently Announced Clinical Trial of GMI-1359
ROCKVILLE, Md.--(BUSINESS WIRE)--GlycoMimetics, Inc. (NASDAQ: GLYC) today announced the publication of a paper in Nature Cell Biology that describes how tumor cells engage specific stromal components, . . .
Posted on 4/19/19
Danaher's Q1 Looked Good, and a Big Acquisition Is on the Way
Danaher Corporation (NYSE:DHR) reported mixed results when it announced its fourth-quarter results in January. Revenue increased by 5.5% year over year, but earnings decreased by 13%.Investors . . .
Posted on 4/17/19
Cannabics Pharmaceuticals Announces Initiation of a Nationwide Clinical Study to Evaluate Antitumor Properties of Cannabinoid Compounds on Primary Cancer Biopsies
Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects, today announced that it has obtained approval for . . .
Posted on 4/17/19
ivWatch Becomes Tech Center Research Park Anchor
NEWPORT NEWS, Va.--(BUSINESS WIRE)--ivWatch, a medical device manufacturer and biosensor technology company focused on improving patient safety and the effectiveness of intravenous (IV) therapy, announced the . . .
Posted on 4/17/19
RRD International Expands Clinical Pharmacology Capabilities
RRD International, a specialized product development company that provides strategic and operational support to biopharmaceutical companies and investors, today announced further expansion of its clinical pharmacology . . .
Posted on 4/17/19
VCU Launches Center For Pharmaceutical Engineering And Sciences
Virginia Commonwealth University has launched an initiative focused on creating drug products.The Center for Pharmaceutical Engineering and Sciences is a collaboration between the university’s School of . . .
Posted on 4/17/19
Hampton Roads Medical Device Firm Raised Money, Expanding
Photo: ivWatch LLCA growing medical device manufacturer has gotten a shot in the arm and finalized a lease for a new Hampton Roads research park, where . . .
Posted on 4/17/19
2019’s Best & Worst States for Children’s Health Care – WalletHub Study
Raising a child in America is extremely expensive, costing the average parent over $230k, and health care accounts for a big chunk of the bill. And . . .
Posted on 4/16/19
Rexahn and BioSense Global Announce Collaboration and License Agreement for RX-3117 in Greater China
ROCKVILLE, Md. and SUZHOU, China, April 16, 2019 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American: RNN), a clinical stage, biopharmaceutical company focused on oncology, and . . .
Posted on 4/16/19
Alteon Health Expands Hospitalist Care To Long-Time Health System Partners
Underscoring the quality and performance of Alteon Health's physicians, three health systems with long ties to the industry-leading medical group have selected Alteon to assume management . . .
Posted on 4/16/19
AllyAlign Health Raises $10M Round Led by McKesson Ventures
AllyAlign Health (AAH), a Richmond-based developer and administrator of Medicare Advantage special need plans that benefit long-term care (LTC) providers
Posted on 4/15/19
Paragon Biosciences Acquired By Catalent for $1.2 Billion
Catalent, Inc. (NYSE:CTLT), the leading global diversified provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products
Posted on 4/15/19
Novavax: I'll Take Capitulation And Despondency Before Hope
Summary There has been a debate about the prospects Novavax and should investors have "Hope" in the company. Both sides have their points and appear to . . .
Posted on 4/15/19
GlycoMimetics Announces Plans to Initiate Breast Cancer Trial to Evaluate GMI-1359
ROCKVILLE, Md.--(BUSINESS WIRE)--GlycoMimetics, Inc. (NASDAQ: GLYC) today announced plans to initiate a clinical trial of GMI-1359 in breast cancer patients whose tumors have spread to bone. . . .
Posted on 4/14/19
Rexahn Effects 1-for-12 Reverse Stock Split
ROCKVILLE, MD, April 12, 2019 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American: RNN), a clinical-stage biopharmaceutical company developing innovative therapies to improve patient outcomes in . . .
Posted on 4/14/19
Beltsville Based NextCure Readies IPO
NextCure (NXTC) has filed a preliminary prospectus for an $86M IPO. The Beltsville, MD-based biopharmaceutical firm develops immunotherapies for cancer and immune-related disorders that act by . . .
Posted on 4/11/19
ChoiceOne Urgent Care Partners with Coppermine Fieldhouse
ChoiceOne Urgent Care (ChoiceOne) in partnership with University of Maryland St. Joseph Medical Center is pleased to announce a new community sponsorship opportunity with Coppermine Fieldhouse, . . .
Posted on 4/11/19
Orgenesis Announces Collaboration and License Agreement for Exosome-Related Technologies with ExcellaBio
GERMANTOWN, Md., April 11, 2019 (GLOBE NEWSWIRE) -- Orgenesis Inc. (NASDAQ: ORGS), a developer, manufacturer and service provider of advanced cell therapies, today announced that it . . .

